BMY
Bristol-Myers Squibb Company · Healthcare · Drug Manufacturers - General
Señales de momentum (gestores comparables):
amplitud de titulares +5.3% ·
flujo de acciones +6.8% ·
nuevas posiciones netas +5.0%
· fórmula
Acumulación amplia: acciones en aumento entre más titulares
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q3 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 2.35M | $122.19M | n/a | n/a |
| Q2 2026 | 174 | +1 | 1.33B | $76.64B | +6 | −4 |
| Q1 2026 | 175 | +1 | 1.27B | $76.90B | +4 | −4 |
| Q4 2025 | 173 | +1 | 1.36B | $73.29B | +2 | n/a |
| Q3 2025 | 26 | 0 | 840.35M | $37.89B | n/a | −1 |
| Q2 2025 | 24 | +1 | 649.62M | $30.06B | +2 | −1 |
| Q1 2025 | 20 | 0 | 256.22M | $15.62B | +1 | −1 |
| Q4 2024 | 20 | -1 | 253.42M | $14.33B | n/a | −1 |
| Q3 2024 | 20 | +1 | 169.93M | $8.78B | +1 | n/a |
| Q2 2024 | 19 | n/a | 159.17M | $6.60B | n/a | n/a |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (pasivo) | 43.20M | +2.5% | $2.23B | 0.2% | ▲ Add | 2 | SEC ↗ ×2 |
| 2 | Norges Bank ✦ (pasivo) | 34.38M | +5.5% | $1.78B | 0.2% | ▲ Add | 2 | SEC ↗ |
| 3 | PRIMECAP Management ✦ | 23.37M | -0.6% | $1.21B | 0.9% | ▼ Trim | 2 | SEC ↗ |
| 4 | T. Rowe Price ✦ | 20.24M | +32.3% | $1.05B | 0.1% | ▲ Add | 2 | SEC ↗ ×2 |
| 5 | Dodge & Cox ✦ | 15.63M | -0.9% | $808.58M | 0.5% | ▼ Trim | 2 | SEC ↗ |
| 6 | Millennium Management ✦ | 5.19M | +247.9% | $268.29M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 7 | Citadel Advisors ✦ | 5.12M | -53.5% | $263.16M | 0.3% | ▼ Trim | 2 | SEC ↗ ×3 |
| 8 | Two Sigma Investments ✦ | 4.72M | -23.5% | $244.28M | 0.6% | ▼ Trim | 2 | SEC ↗ |
| 9 | Adage Capital Partners ✦ | 4.49M | +415.6% | $232.53M | 0.4% | ▲ Add | 2 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 3.90M | +45.7% | $200.47M | 0.3% | ▲ Add | 2 | SEC ↗ ×5 |
| 11 | Point72 Asset Management ✦ | 2.88M | +351.5% | $149.03M | 0.5% | ▲ Add | 2 | SEC ↗ |
| 12 | Arrowstreet Capital ✦ | 2.03M | -30.4% | $105.09M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 13 | D. E. Shaw & Co. ✦ | 1.56M | -36.5% | $80.65M | 0.1% | ▼ Trim | 2 | SEC ↗ ×2 |
| 14 | Renaissance Technologies ✦ | 908.54K | Nuevo | $47.01M | 0.1% | New | 1 | SEC ↗ |
| 15 | Marshall Wace ✦ | 868.11K | +239.5% | $44.92M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 16 | Bridgewater Associates ✦ | 610.36K | +10.0% | $31.58M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 17 | Gotham Asset Management ✦ | 337.01K | +17.5% | $17.44M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 18 | Fisher Asset Management ✦ | 226.48K | -0.7% | $11.72M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 19 | Wellington Management ✦ | 150.19K | -9.9% | $7.77M | 0.0% | ▼ Trim | 2 | SEC ↗ ×4 |
| 20 | GAMCO Investors ✦ | 110.89K | -0.5% | $5.74M | 0.1% | ▼ Trim | 2 | SEC ↗ |
"Their weight" = la participación de la posición en el valor de renta variable 13F reportado por ese manager: la medida de convicción. ✦ = manager curado.
Nuevos compradores
| Renaissance Technologies | $47.01M | 0.1% |
Posición cerrada
| Sin salidas rastreadas este trimestre. |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 1 tenedores, 6.60K acciones, $400 declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué más suelen tener los titulares rastreados de este valor: recuentos de titularidad compartida, no relaciones fundamentales.
Compras en mercado abierto (P)
Sin compras en mercado abierto por parte de insiders en nuestra ventana de cobertura.
Ventas en mercado abierto (S)
Officer · 6.25K acc. · $403,498
Officer · 500 acc. · $33,750
Las adjudicaciones, ejercicios y retenciones fiscales nunca se contabilizan aquí como compras o ventas. Metodología